Menu

Welcome to the European Association for Cancer Research
Europe’s membership association for cancer researchers

Nanotechnology in Cancer: Engineering for Oncology

Cambridge, UK : 12 - 14 September 2019

Scientific Programme

To download and print the programme, use the links below.

12:00

Registration

12:30

welcome lunch

13:30

Conference Welcome

Kostas Kostarelos (SPC Chair)

SESSION 1: EFFECTIVE TRANSPORT OF siRNA, mRNA, CRISPR-Cas9

Chair: Kostas Kostarelos

13:35

The EMBO Keynote Lecture

René Bernards NKI, Netherlands

"A one-two punch model for cancer therapy"

14:20

Michelle Bradbury MSKCC, USA

"Next-generation ultrasmall silica nanoparticle solutions for overcoming biological barriers to molecularly-targeted drug delivery"

14:50

Aditi Mehta Ludwig Maximilians University of Munich, Germany

Proffered Paper 1: "Nano-Particles for in vivo genome editing mediated by CRISPR-cas9 for undruggable KRAS driven lung cancers"

15:05

EXHIBITOR INTRODUCTIONS

60-second intro pitches by each company

15:15

COFFEE BREAK & TRADE

15:45

Olivia Merkel LMU, Germany

"Correlating quantitative tumor accumulation and gene knockdown using SPECT/CT and bioluminescence imaging within an orthotopic ovarian cancer model"

16:15

Twan Lammers University Hospital Aachen, Germany

"Smart cancer nanomedicine"

16:45

Angela Pine University of Essex, UK

Proffered Paper 2: "The development of gene therapy by way of DNAzymes"

17:00

Marianne Ashford AstraZeneca, UK

"Developing Nanomedicines to enable Innovative Cancer Therapy - Lipid Nanoparticles as a delivery system for nucleic acid-based drugs"

17:30

POSTER SPOTLIGHTS

3 top abstracts presented as 3 minute flash talks

17:45

Networking Reception

including drinks and light food

18:15

Poster Discussion Session 1 & Trade Exhibition

Until 19:45

SESSION 2: DETECTION AND TREATMENT OF EARLY STAGE DISEASE

Chair: Caroline Dive

09:00

Keynote Lecture

Mark Dewhirst Duke Cancer Institute, USA

"Development of a thermally triggered liposomal drug delivery platform: a bench to bedside story"

09:45

Cristianne Rijcken Cristal Therapeutics, the Netherlands

"CriPec® platform and lead product CPC634: principles, nonclinical evaluation and clinical translation”

10:15

Aria Ahmed-Cox Children's Cancer Institute Australia

Proffered Paper 3: "Seeing is believing: Quantitative analysis of nanoparticle uptake kinetics and cellular localisation in a three dimensional brain tumour model"

10:30

Hanan Abumanhal-Masarweh Technion Institute of Technology, Israel

Proffered Paper 4: "Modulating the Tumour pH: Liposomal bi-carbonate enhance doxorubicin activity in breast cancer"

10:45

COFFEE BREAK & TRADE

11:15

Speaker to be confirmed

11:45

Claire Wilhelm Paris Diderot University, France

"Optimal application windows for magnetic hyperthermia, photothermia, and magneto-photo-thermia with magnetic and plasmonic nanoparticles, in cancer treatment"

12:15

POSTER SPOTLIGHTS

3 top abstracts presented as 3 minute flash talks

12:30

LUNCH

13:15

POSTER DISCUSSION SESSION 2

SESSION 3: EXOSOMES, PROTEINS & NUCLEIC ACID MARKERS

Chair: Claire Wilhelm

14:45

Keynote Lecture

Molly Stevens Imperial College London, UK

"Engineering the bio-material interface for cancer applications "

15:30

Caroline Dive CRUK Manchester Institute, UK

"Liquid biopsies for early detection of lung cancer - nanotechnologists help required!"

16:00

Marilena Hadjidemetriou University of Manchester, UK

Proffered Paper 5: "Nano-omics enrichment tools for cancer biomarker discovery"

16:15

COFFEE BREAK & TRADE

16:45

Enrico Iaccino Magna Græcia University, Italy

Proffered Paper 6: "In vivo phage display-based platform for tumour detection and tumour derived exosomes trapping"

17:00

Kostas Kostarelos University of Manchester, UK

17:30

Raymond Schiffelers UMC Utrecht, Netherlands

"RNA delivery with synthetic nanomedicines and extracellular vesicles"

19:30

CONFERENCE DINNER

Churchill College Dining Hall

Free tickets are available to all participants.

09:00

Meet the Expert

Caroline Dive CRUK Manchester Institute, UK

In this session our speaker will share from her personal and professional perspectives on the path to scientific leadership and women in science.

SESSION 4: MORE EFFECTIVE, TARGETED IMMUNOTHERAPY

Chair: Raymond Schiffelers

09:30

Ronit Satchi-Fainaro Tel Aviv University, Israel

"Ibrutinib sensitizes melanoma to immune checkpoint modulators following immunisation with nano-vaccines by relieving immune-suppressing microenvironment"

10:00

Helena Florindo University of Lisbon, Portugal

Proffered Paper 7: "Multi-targeting nano based platform as an effective immunotherapy against solid tumours"

10:15

Rakesh Dixit Bionavigen, USA

"Safety and pharmacokinetic challenges to the development of nanomedicines"

10:45

COFFEE BREAK & TRADE

11:15

Raphaël Lévy University of Liverpool, UK

Proffered Paper 8: "Are We Building on the Shoulders of Giants or on a Nanobubble?"

11:30

Shiladitya Sengupta Harvard Medical School, USA

"Cancer Immunology at the Nanoscale"

12:00

Keynote Lecture

Darrell Irvine MIT, Boston, USA

"Using nanomaterials to engineer anti-cancer immunity"

12:45

Conference Summary

Scientific Programme Committee

13:00

LUNCH & DEPART

Session at Churchill College. 

Sorry. You need to upgrade your browser

You are using Internet Explorer 8

This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.

Thank you.